A guide to selecting high-performing antibodies for Cathepsin B (UniProt ID: P07858) for use in western blot

This report presents a guide to selecting high-quality commercial antibodies against Cathepsin B (CTSB) in western blot using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic controls. This study was funded in part by the Michael J. Fox Foundation (MJFF) for Parkinson's disease.

Institutions

Montreal Neurological Institute and Hospital (CA)

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2024-12-10
DOI: https://doi.org/10.5281/zenodo.14365864
Primary Topic: Protease and Inhibitor Mechanisms
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A guide to selecting high-performing antibodies for Cathepsin B (UniProt ID: P07858) for use in western blot

Dec 10, 2024

Zenodo (CERN European Organization for Nuclear Research)

Protease and Inhibitor Mechanisms

article

A guide to selecting high-performing antibodies for Cathepsin B (UniProt ID: P07858) for use in western blot

December 10, 2024article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Montreal Neurological Institute and Hospital (CA)

Partnerships for the goals

Openalex Percentile: Top 54%

Protease and Inhibitor Mechanisms

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.